Your Gateway to GMP Compliance and Pharmaceutical Excellence
Impact of PIC/S on GMP Compliance in LMICs How PIC/S Enhances GMP Compliance in Low- and Middle-Income Countries The Pharmaceutical Inspection Co-operation Scheme (PIC/S) is widely recognized for harmonizing GMP standards globally. However, one of its most transformative roles is its support for GMP compliance in Low- and Middle-Income Countries (LMICs). These nations face unique…
How Companies Can Prepare for a PIC/S-Led Inspection Preparing Your Company for a Successful PIC/S GMP Inspection A Pharmaceutical Inspection Co-operation Scheme (PIC/S)-led inspection is a significant event for any pharmaceutical company. These inspections are conducted by competent authorities from member countries, applying harmonized Good Manufacturing Practice (GMP) standards across the globe. Success depends on…
Read More “How Companies Can Prepare for a PIC/S-Led Inspection” »
Data Integrity and Documentation in PIC/S Inspections Ensuring Data Integrity and Documentation Compliance in PIC/S Inspections In the pharmaceutical industry, data integrity and documentation control form the foundation of GMP compliance. As regulators intensify their focus on these areas, companies must be prepared to meet the stringent expectations outlined by the Pharmaceutical Inspection Co-operation Scheme…
Read More “Data Integrity and Documentation in PIC/S Inspections” »
Risk-Based Inspection Approaches in PIC/S Implementing Risk-Based Inspection Strategies Under PIC/S Framework The global pharmaceutical regulatory landscape has steadily evolved from fixed-schedule inspections to dynamic, risk-based approaches. Under the Pharmaceutical Inspection Co-operation Scheme (PIC/S), member authorities apply harmonized risk models to optimize inspection frequency, depth, and focus. These strategies are critical to resource efficiency, proactive…
Understanding the PIC/S Inspection Report Format How to Interpret the PIC/S Inspection Report Format Effectively The Pharmaceutical Inspection Co-operation Scheme (PIC/S) promotes standardized inspection formats to ensure transparency and consistency in GMP enforcement across member countries. A critical outcome of every inspection is the inspection report, which communicates the compliance status of a pharmaceutical facility….
Read More “Understanding the PIC/S Inspection Report Format” »
Use of PIC/S Inspection Outcomes in Regulatory Submissions Leveraging PIC/S Inspection Outcomes in Regulatory Submissions In today’s globally harmonized pharmaceutical landscape, regulatory submissions require more than just clinical data—they demand verifiable proof of Good Manufacturing Practice (GMP) compliance. The Pharmaceutical Inspection Co-operation Scheme (PIC/S) plays a central role in this ecosystem by offering harmonized GMP…
Read More “Use of PIC/S Inspection Outcomes in Regulatory Submissions” »
Handling Non-Compliance Findings from PIC/S Member Inspections Managing Non-Compliance Findings from PIC/S Member Inspections Receiving a non-compliance finding from a PIC/S member inspection can be challenging, but with a structured and timely response, it also presents an opportunity to strengthen your quality system. As regulatory authorities rely increasingly on harmonized GMP frameworks under PIC/S, companies…
Read More “Handling Non-Compliance Findings from PIC/S Member Inspections” »
Role of PIC/S in Joint and Remote Inspections How PIC/S Enhances Joint and Remote GMP Inspections Worldwide The evolution of pharmaceutical oversight has expanded beyond traditional on-site audits to include joint and remote inspections. The Pharmaceutical Inspection Co-operation Scheme (PIC/S) plays a pivotal role in coordinating these multi-national and virtual inspection models to ensure harmonized…
Advanced Therapies and Biologics in the PIC/S Inspection Model How PIC/S Tailors Inspections for Advanced Therapies and Biologics Biologics and advanced therapy medicinal products (ATMPs) such as gene therapy, cell therapy, and tissue-engineered products are transforming modern medicine. These complex products pose unique Good Manufacturing Practice (GMP) challenges, requiring specialized regulatory oversight. The Pharmaceutical Inspection…
Read More “Advanced Therapies and Biologics in the PIC/S Inspection Model” »
GMP Audit Trends Observed in PIC/S Annual Reports Key GMP Audit Trends Revealed in PIC/S Annual Reports As global regulatory scrutiny intensifies, pharmaceutical manufacturers increasingly rely on insights from regulatory bodies to benchmark and improve compliance. The Pharmaceutical Inspection Co-operation Scheme (PIC/S) publishes annual reports that detail audit activities across its member countries. These reports…
Read More “GMP Audit Trends Observed in PIC/S Annual Reports” »